We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Anesthesiology

RAI Outperforms mFI-5 in Predicting Post-UPPP Complications: A Frailty Stratification Breakthrough

MedXY Editorial Team•Apr 23, 2026•Anesthesiology
frailty assessmentrisk stratificationsleep surgery术后并发症

Background

Uvulopalatopharyngoplasty (UPPP) remains a cornerstone surgical intervention for obstructive sleep apnea (OSA), yet current preoperative risk stratification relies heavily on anatomic and disease-severity measures. These fail to account for physiologic vulnerability, leaving clinicians without robust tools to predict postoperative complications. This study addresses a critical gap by comparing two frailty metrics—the Risk Analysis Index (RAI) and modified frailty index-5 (mFI-5)—in stratifying risk among UPPP patients.

Study Design

The retrospective cohort analysis included 2,129 adults who underwent UPPP between 2005 and 2020. Frailty was assessed preoperatively using RAI (a validated 14-item tool evaluating comorbidities, functional status, and nutrition) and mFI-5 (a 5-item comorbidity-based index). Outcomes included Clavien-Dindo complications (CD II/IV), extended length of stay (eLOS), non-home discharge (NHD), and mortality. Multivariable logistic regression and receiver operating characteristic (ROC) analyses determined predictive performance.

Key Findings

Frailty and Adverse Outcomes

Severe frailty (RAI >31) demonstrated striking associations: 21-fold higher odds of CD II complications (OR 21.3, 95% CI 3.7-123.8), 4.6-fold increase in CD IV events (OR 4.6, 2.0-10.6), and 17.5-fold elevated deep surgical site infection risk (OR 17.5, 1.7-176.3). mFI-5 >3 predicted CD II, eLOS, and NHD but failed to capture CD IV or DSSI.

Discriminatory Performance

RAI consistently surpassed mFI-5, with superior area-under-curve values for mortality (0.813 vs. 0.580), CD II (0.784 vs. 0.652), and eLOS (0.767 vs. 0.669). For NHD, RAI’s AUC was 0.767 versus mFI-5’s 0.618.

Expert Commentary

“This study pivots the conversation from anatomic to physiologic risk assessment,” notes Dr. A. Khan (uninvolved otolaryngologist). However, limitations include retrospective design and potential selection bias. The findings may not generalize to outpatient UPPP or pediatric populations.

Conclusion

RAI’s superior predictive validity supports its integration into preoperative workflows, potentially reducing complications through targeted resource allocation. Future research should validate these findings prospectively and explore RAI’s utility in other sleep surgeries.

Funding and Registration

Study funding was undisclosed. No clinical trial registration was reported (retrospective design).

References

1. Warrier A et al. The Laryngoscope. 2026; PMID: 41989010
2. Rockwood K et al. CMAJ. 2005; Frailty indices literature
3. Velanovich V. J Am Coll Surg. 2020; RAI validation studies

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple MyelomaSoluble BCMA levels in newly diagnosed multiple myeloma patients reveal distinct tumor phenotypes and predict prognosis more strongly than tumor volume, enabling improved risk stratification and clinical decision-making.Sep 27, 2026MTMR4 Gene Variants: Divergent Impact on Arrhythmic Risk in Type 1 and 2 Long QT SyndromeMTMR4 minor allele homozygosity influences arrhythmic risk oppositely in LQT1 and LQT2, providing critical insights for personalized risk stratification in long QT syndrome patients.Sep 25, 2026Tailored Screening Intervals for Relatives Carrying TTN Truncations: Enhancing Dilated Cardiomyopathy ManagementA gene-specific, risk-based screening algorithm for relatives with titin-truncating variants optimizes monitoring intervals from 1 to 5 years, improving safety and resource use in dilated cardiomyopathy surveillance.Sep 23, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Standalone Salpingectomy for Primary Ovarian Cancer Prevention: A Cost-Effectiveness Analysis
This review synthesizes evidence on the cost-effectiveness of standalone salpingectomy for ovarian cancer prevention, highlighting its benefits primarily in women at moderately elevated risk, especially between ages 45-50, supporting tailor
Sep 23, 2026
Reevaluating Angiography in the Diagnosis and Management of Intraluminal Hemorrhage Following Pancreatoduodenectomy: Insights from 115 Cases Among 3,011 SurgeriesThis study highlights the diagnostic and therapeutic value of angiography in intraluminal postpancreatoduodenectomy hemorrhage, revealing its superiority in bleeding source localization and effective hemostasis compared to other modalities.Sep 17, 2026
Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical FactorsA novel, cumulative risk factor approach identifies patients at increased risk for additional retinal intervention after laser retinopexy for retinal tears, improving surveillance and management strategies.Sep 15, 2026